RSV is a highly infectious, common virus that usually causes mild ... with the most prominent being a rash and soreness at the injection site, according to the FDA. Maldonado said it’s hard ...

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Additionally, nasopharyngeal RSV viral load reduction from baseline at ... elevated liver-enzymes, rash, and thrombocytosis.

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

A recent study found that the respiratory syncytial virus vaccine was highly effective in older U.S. veterans during the 2023-2024 respiratory illness season. The study, published Jan. 20 in The ...